Last update 17 Apr 2025

SC-1-151 (Duquesne University)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SC-1-151, SC-1-151 (Duquesne University/Tulane University)
Target
MAP2K5 x MEK1 x MEK2
Action
inhibitors
Mechanism
MAP2K5 inhibitors(mitogen-activated protein kinase kinase 5 inhibitors), MEK1 inhibitors(Dual specificity mitogen-activated protein kinase kinase 1 inhibitors), MEK2 inhibitors(Dual specificity mitogen-activated protein kinase kinase 2 inhibitors)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Triple Negative Breast Cancer
Originator Organization
Duquesne University of The Holy SpiritDuquesne University of The Holy Spirit
Active Organization-
Inactive Organization
Duquesne University of The Holy SpiritDuquesne University of The Holy SpiritTulane University Hospital & ClinicTulane University Hospital & Clinic
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with SC-1-151 (Duquesne University)
Login to view more data
100 Translational Medicine associated with SC-1-151 (Duquesne University)
Login to view more data
100 Patents (Medical) associated with SC-1-151 (Duquesne University)
Login to view more data
100 Deals associated with SC-1-151 (Duquesne University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Triple Negative Breast CancerPreclinical
United States
Duquesne University of The Holy SpiritDuquesne University of The Holy Spirit
01 Oct 2014
Triple Negative Breast CancerPreclinical
United States
Tulane University Hospital & ClinicTulane University Hospital & Clinic
01 Oct 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free